IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 6, 2009, Pages

  Nograles, Kristine E ^a   Zaba, Lisa C ^a   Shemer, Avner ^b   Fuentes Duculan, Judilyn ^a   Cardinale, Irma ^a   Kikuchi, Toyoko ^a   Ramon, Michal ^c   Bergman, Reuven ^c   Krueger, James G ^a   Guttman Yassky, Emma ^a,d  

^a ROCKEFELLER UNIVERSITY   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Atopic dermatitis; IL 17; IL 22; psoriasis; T22; TH17

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADULT; ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS HYPERPLASIA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; SKIN INFLAMMATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; CHRONIC DISEASE; HELPER CELL; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; CHRONIC DISEASE; DERMATITIS, ATOPIC; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKINS; MIDDLE AGED; PSORIASIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 67649161002     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.03.041     Document Type: Article

References (27)

1. Li J., Chen X., Liu Z., Yue Q., and Liu H. Expression of Th17 cytokines in skin lesions of patients with psoriasis. J Huazhong Univ Sci Technolog Med Sci 27 (2007) 330-332
2. Lowes M.A., Kikuchi T., Fuentes-Duculan J., Cardinale I., Zaba L.C., Haider A.S., et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128 (2008) 1207-1211
3. Nograles K.E., Zaba L.C., Guttman-Yassky E., Fuentes-Duculan J., Suarez-Farinas M., Cardinale I., et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159 (2008) 1092-1102
4. Kryczek I., Bruce A.T., Gudjonsson J.E., Johnston A., Aphale A., Vatan L., et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 181 (2008) 4733-4741
5. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007) 648-651
6. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271-2279
7. Boniface K., Bernard F.X., Garcia M., Gurney A.L., Lecron J.C., and Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174 (2005) 3695-3702
8. Sa S.M., Valdez P.A., Wu J., Jung K., Zhong F., Hall L., et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 178 (2007) 2229-2240
9. Ma H.L., Liang S., Li J., Napierata L., Brown T., Benoit S., et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118 (2008) 597-607
10. Boniface K., Guignouard E., Pedretti N., Garcia M., Delwail A., Bernard F.X., et al. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 150 (2007) 407-415
11. Toda M., Leung D.Y., Molet S., Boguniewicz M., Taha R., Christodoulopoulos P., et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 111 (2003) 875-881
12. Koga C., Kabashima K., Shiraishi N., Kobayashi M., and Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 128 (2008) 2625-2630
13. Guttman-Yassky E., Lowes M.A., Fuentes-Duculan J., Zaba L.C., Cardinale I., Nograles K.E., et al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 181 (2008) 7420-7427
14. Lubberts E., Joosten L.A., Chabaud M., van Den Bersselaar L., Oppers B., Coenen-De Roo C.J., et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest 105 (2000) 1697-1710
15. Seshasayee D., Lee W.P., Zhou M., Shu J., Suto E., Zhang J., et al. In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest 117 (2007) 3868-3878
16. Li J., Li L., Shang X., Benson J., Merle Elloso M., Schantz A., et al. Negative regulation of IL-17 production by OX40/OX40L interaction. Cell Immunol 253 (2008) 31-37
17. Eyerich K., Pennino D., Scarponi C., Foerster S., Nasorri F., Behrendt H., et al. IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol 123 (2009) 59-66
18. Guttman-Yassky E., Lowes M.A., Fuentes-Duculan J., Whynot J., Novitskaya I., Cardinale I., et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol 119 (2007) 1210-1217
19. de Jongh G.J., Zeeuwen P.L., Kucharekova M., Pfundt R., van der Valk P.G., Blokx W., et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 125 (2005) 1163-1173
20. Kim B.E., Leung D.Y., Boguniewicz M., and Howell M.D. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 126 (2008) 332-337
21. Man M.Q., Barish G.D., Schmuth M., Crumrine D., Barak Y., Chang S., et al. Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol 128 (2008) 370-377
22. Howell M.D., Kim B.E., Gao P., Grant A.V., Boguniewicz M., Debenedetto A., et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 120 (2007) 150-155
23. Proksch E., Brandner J.M., and Jensen J.M. The skin: an indispensable barrier. Exp Dermatol 17 (2008) 1063-1072
24. O'Regan G.M., and Irvine A.D. The role of filaggrin loss-of-function mutations in atopic dermatitis. Curr Opin Allergy Clin Immunol 8 (2008) 406-410
25. Jung T., and Stingl G. Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights. J Allergy Clin Immunol 122 (2008) 1074-1081
26. Oflazoglu E., Simpson E.L., Takiguchi R., Hanifin J.M., Grewal I.S., and Gerber H.P. CD40 expression on antigen presenting cells and correlation with disease severity in atopic dermatitis. Eur J Dermatol 18 (2008) 527-533
27. Hennino A., Vocanson M., Toussaint Y., Rodet K., Benetiere J., Schmitt A.M., et al. Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions. J Immunol 178 (2007) 5571-5577